The latest news on Pfizer, including vaccine updates
The investment heroes and villains of 2018
Drugmakers accused of working with anti-American Iraqi militia
Medecins Sans Frontieres accuses pharma firm of withholding Aids drug
The 10 best actively managed dividend income-paying funds
'Skinny-obese' people and the fight against visceral fat
We can all do our bit to stop antibiotic overuse
King Abdullah Economic City courts investors, port may IPO
Pfizer pays US$14bn to wrest Medivation from under rivals’ noses
India’s ailing pharmaceutical industry needs a cure
A price paid by the poor: Vaccines cost nearly 70 times what they did in 2001
AstraZeneca rejects $117bn ‘final takeover offer’ from Pfizer
Neopharma in generic drug production deal with Pfizer unit